Genmab — Maj 2020

[Bulder]

Bibob, han har ikke vurderet tallene. Det er konkrete lave IMS-tal, som tyder på tilsvarende lave SH-tal.

[Plimsoller]

God morgen

[bibob]

God morgen.

[bibob]

@ bulder 20.18. Ok, havde overset IMS tal.

[transalp]

Go morgen..

[Helge_LarsenPI-redaktør]

God morgen.

[bongobob]

Morn. Ny forskning. Optimering af ADCC mekanismen. Ny platform? https://www.frontiersin.org/articles/10.3389/fimmu.2020.00740/full

[Sukkeralf]

Tak bongobob

[E_L]

https://twitter.com/DrOlaLandgren/status/1259521252403879936

[E_L]

finans.dk/ https://finans.dk/erhverv/ECE12130169/genmab-naermer-sig-ny-milliardaftale-vi-koerer-mest-aggressivt-frem-med-en-af-aktoererne/?utm_source=dlvr.it&utm_medium=twitter&ctxref=ext

[lahn1]

EL - Nice to see Rajkumar promoting DARA SC

[E_L]

yes. i was however more posting it for this line: NCCN Guidelines 4.2020 for Myeloma have SC added to all regimens containing daratumumab (so that is more broad as in the press release?)

[Sukkeralf]

Yes I also niced that - great

[Solsen]

Kåre Schultz mener covid-19 ændrer på hvorledes man sælger medicin på i fremtiden. Færre kilometer og venten fra sælgernes side. Færre salgsomkostninger. Jf Børsen https://borsen.dk/nyheder/virksomheder/kaare-schultz-covid-19-skaber-varig-forandring. Det set up Genmab har arbejdet på

[Sukkeralf]

Ja godt for ofa og dara

[bibob]

5 C25 aktier over 60 % på styrkebarometer. ØU. https://ugebrev.dk/flashnews/investering/fem-c25-over-60-paa-styrkebarometer-staerkest-er-pandora-71/

[Bulder]

Looks like NCCN guidelines also covers dara in frontline transplant setting, which is not included in the approval message. I have a Q for Winkel about that just to be sure.

[E_L]

good idea!

[E_L]

@bongobob was it not possible to find an easier article to post on a monday morning?? I am wondering if it has anyting to do with Covid-1 research , also since they work together with the Dutch blood bank?

[bongobob]

It’s fascinating to see scientists in action and how they stand on each others shoulders. Like this:” The infants of mothers carrying this IgG3 polymorphic variant were found to have an increased protection against malaria, most likely caused by the malaria specific IgG3 antibodies crossing the placental membrane more efficiently as a result of increased binding to FcRn”